Aberdeen University Featured PhD Programmes
University of Kent Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
University of Oxford Featured PhD Programmes
Cardiff University Featured PhD Programmes

Cancer / Oncology (group) PhD Projects, Programs & Scholarships

We have 154 Cancer / Oncology (group) PhD Projects, Programs & Scholarships

  • "group" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 141 to 150 of 154
  Integrative Computational Biology and Machine Learning
  Dr A Sahakyan
Application Deadline: 10 January 2020

Funding Type

PhD Type

In Sahakyan Group, we strive to make computational biology maximally independent from empirical experimental data, by basing our models and predictions on genomic sequences and core biological mechanisms.
  Tumour microenvironment and colorectal cancer development: understanding the mechanisms of the tumour growth
  Prof D Kerr, Dr S Cai
Application Deadline: 10 January 2020

Funding Type

PhD Type

Our group has conducted a series of international adjuvant trials of chemotherapy for colorectal cancer (Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 – 1557).
  Integrative Computational Biology and Machine Learning
  Dr A Sahakyan
Application Deadline: 10 January 2020

Funding Type

PhD Type

In Sahakyan Group, we strive to make computational biology maximally independent from empirical experimental data, by basing our models and predictions on genomic sequences and core biological mechanisms.
  Design and synthesis of novel, targeted, anti-cancer agents
  Prof H Osborn, Dr F Greco
Applications accepted all year round

Funding Type

PhD Type

One of the major problems of cancer chemotherapy is that the drugs used have poor selectivities for cancer cells and cause damage to normal cells and organs.
  Enhancing MHC Presentation of Antigenic Peptides for Cancer Gene Therapy
  Dr A Brown
Application Deadline: 29 January 2020

Funding Type

PhD Type

Anti-cancer immune responses can be stimulated by in vivo expression of tumour antigens in dendritic cells.
  Adrenomedullin-2 receptor antagonists in T-cell lymphoma
  Dr G Richards, Prof T Skerry
Applications accepted all year round

Funding Type

PhD Type

Cancer cells rely upon communication between themselves and to the host tissues to survive and grow. One hormone involved in cancer signalling is adrenomedullin (AM), which also has important physiological roles in the control of blood pressure.
  Evaluation of natural and novel tumour-selective cannabinoids in melanoma progression and metastases
  Dr A Idris, Dr S Danson
Application Deadline: 31 January 2020

Funding Type

PhD Type

The majority of deaths from melanoma following conventional therapies are a result of metastases.
  MRC DiMeN Doctoral Training Partnership: Activation of Aurora Kinase A by DNA damage – understanding the signalling pathway to improve radiotherapy response
  Dr H Bryant, Prof C Eyers, Prof P Eyers
Application Deadline: 6 January 2020

Funding Type

PhD Type

Radiation is a mainstay of cancer therapy, however radioresistance is a significant challenge in the treatment of locally advanced, recurrent and metastatic cancers.
  MRC DiMeN Doctoral Training Partnership: Understanding the role of DRAM in infection and autophagy-related disease
  Dr J King, Dr P Elks
Application Deadline: 6 January 2020

Funding Type

PhD Type

Intracellular degradation by lysosomes is important in a wide range of diseases. The capture and degradation of cytoplasmic components by autophagy allows tumour cells to survive starvation and neurons to remove the protein aggregates associated with neurodegeneration.
  The EV-glycome: the coming of age of a novel biomarker?
  Dr D Lambert, Dr G Stafford
Application Deadline: 29 January 2020

Funding Type

PhD Type

Cellular senescence is the permanent loss of a cell’s ability to divide. Although no longer dividing, senescent cells remain metabolically active and develop a secretory, inflammatory phenotype termed the SASP.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.